Anzeige
Erschienen in:
07.09.2017 | Original articles
Genome-wide DNA methylation patterns in coronary heart disease
Erschienen in: Herz | Ausgabe 7/2018
Einloggen, um Zugang zu erhaltenAbstract
Background
To better understand the molecular mechanisms of atherosclerosis, we conducted a comparative analysis of DNA methylation patterns in right coronary arteries in the area of advanced atherosclerotic plaques (CAP), great saphenous vein (GSV), and internal mammary artery (IMA) of patients affected by coronary heart disease.
Methods
DNA methylation data (accession number E‑GEOD-62867) were divided into three paired groups: CAP vs. IMA, CAP vs. GSV, and IMA vs. GSV. Differentially methylated genes (DMGs) were extracted to analyze the changes in the DMGs in the three different tissues. The gplots package was used for the clustering and heatmap analysis of DMGs. Subsequently, DMG-related pathways were identified using DAVID (Database for Annotation, Visualization and Integrated Discovery) and transcription factors (TFs) were predicted.
Results
Based on the filtering criterion of p < 0.05, and a mean beta value difference of ≥0.2, there were 252, 373, and 259 DMGs, respectively, in the CAP vs. IMA, CAP vs. GSV, and IMA vs. GSV groups. Interestingly, the S100A10 gene was hypomethylated in CAP compared with IMA and GSV. Clustering and heatmap analyses suggested that DMGs were segregated into two distinct clusters. Hypermethylated genes in CAP as compared with GSV were only involved in the pathway of fat digestion and absorption, while hypomethylated genes in CAP compared with GSV mainly participated in immune response-associated pathways (cytokine–cytokine receptor interaction, MAPK signaling pathway).
Conclusion
The DNA methylation differences in vascular tissues of patients with coronary artery disease may provide new
insights into the mechanisms underlying the development of atherosclerosis. The functions identified here—cytokine–cytokine receptor interaction, MAPK signaling pathway, DMG (S100A10), and TF (NF-kB)—may serve as potential targets in the treatment of atherosclerosis.